Development and prospective evaluation of an automated software system for quality control of quantitative 99mTc-MAG3 renal studies

Journal of Nuclear Medicine Technology

Volumn 35, Issue 1, 2007, Pages 27-33

  Folks, Russell D ^a   Garcia, Ernest V ^a   Taylor, Andrew T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

99mTc MAG3; MAG3 clearance; Quality control; Renal function

Indexed keywords

MERCAPTOACETYLGLYCINE TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; MERTIATIDE TC 99M;

ADULT; AGED; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; ERROR; EVALUATION; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGIST; PROSPECTIVE STUDY; QUALITY CONTROL; QUANTITATIVE ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; HEALTH CARE QUALITY; KIDNEY DISEASE; KIDNEY SCINTISCANNING; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KIDNEY DISEASES; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFTWARE; SOFTWARE DESIGN; SOFTWARE VALIDATION; TECHNETIUM TC 99M MERTIATIDE;

EID: 34248581294     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, D.C.: National Academy Press; 2000.
2. Leape LL, Berwick DM. Five years after To Err Is Human: what have we learned? JAMA. 2005;293:2384-2390.
3. Strauss BS, Blaufox MD. Estimation of residual urine and urine flow rates without urethral catheterization. J Nucl Med. 1970;11:81-84.
4. 99mTc DTPA diuretic renography. Br J Urol. 1988;61:409-412.
5. Bubeck B. Renal clearance determination with one blood sample: improved accuracy and universal applicability by a new calculation principle. Semin Nucl Med. 1993;23:73-86.
6. Taylor A, Nally J, Aurell M, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. J Nucl Med. 1996;37:1876-1882.
7. Taylor AT Jr, Blaufox MD, Dubovsky EV, et al. Society of Nuclear Medicine procedure guideline for diagnosis of renovascular hypertension, version 3.0, approved June 20, 2003. Available at: http://interactive.snm.org/index.cfm? PageID5772&RPID510. Accessed December 28, 2006.
8. Müller-Suur R, Tidgren B, Lundberg HJ. Effect of captopril on MAG-3 clearance in patients with and without renal arterial stenosis and after PTRA. Eur J Nucl Med. 1998;25:845.
9. Li Y, Russell CD, Palmer-Lawrence J, Dubovsky EV. Quantitation of renal parenchymal retention of technetium-99m-MAG3 in renal transplants. J Nucl Med. 1994;35:846-850.
10. Ash JM, Antico VF, Gilday DL, Houle S. Special considerations in the pediatric use of radionuclides for kidney studies. Semin Nucl Med. 1982;12:345-369.
11. Rossleigh MA, Thomas MY, Moase AL. Determination of the normal range of furosemide half-clearance times when using Tc-99m MAG3. Clin Nucl Med. 1994;19:880-882.
12. Piepsz A, Tondeur M, Ham H. NORA: a simple and reliable parameter for estimating renal output with or without frusemide challenge. Nucl Med Commun. 2000;21:317-323.
13. Wong DC, Rossleigh MA, Farnsworth RH. Diuretic renography with the addition of quantitative gravity-assisted drainage in infants and children. J Nucl Med. 2000;41:1030-1036.
14. 99mTc-MAG3 scans to detect renal obstruction. J Nucl Med. 2006;47:320-329.
15. Folks RD, Taylor AT, Garcia EV. Development of a software module for automating the quality control of quantitative nuclear renography [abstract]. J Nucl Med. 2005;46(suppl):500P.
16. Taylor A Jr, Corrigan PL, Galt J, et al. Measuring technetium-99m-MAG3 clearance with an improved camera-based method. J Nucl Med. 1995;36:1689-1695.
17. Taylor A, Manatunga A, Morton K, et al. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine or Tc-99m MAG3 clearance. Radiology. 1997;204:47-54.
18. Hunsche A, Press H, Taylor A. Increasing the dose of furosemide in patients with azotemia and suspected obstruction. Clin Nucl Med. 2004;29:149-153.
19. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume. AJR. 2006;187:W610-W617.
20. Britton KE, Busemann Sokole E. Quality assurance in nuclear medicine software and "COST." Nucl Med Commun. 1990;11:334-338.
21. Blaufox MD, Aurell M, Bubeck B, et al. Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med. 1996;37:1883-1890.
22. Prigent A, Cosgriff P, Gates GF, et al. Consensus report on quality control of quantitative measurements of renal function obtained from the renogram: international consensus committee from the scientific committee of radionuclides in nephrourology. Semin Nucl Med. 1999;29:146-159.
23. Bergmann H, Mostbeck A, Kletter K, Nicoletti R, Oberladstatter M. Recommendations for carrying out nuclear medicine kidney function tests with a gamma camera and computer. Acta Med Austriaca Suppl. 1991;43:1-19.
24. Cosgriff PS. Quality assurance in renography: a review. Nucl Med Commun. 1998;19:711-716.
25. Houston AS, Whalley DR, Skrypniuk JV, Jarrit PH, Fleming JS, Cosgriff PS. UK audit and analysis of quantitative parameters obtained from gamma camera renography. Nucl Med Commun. 2001;22:559-566.
26. Heikkinen JO, Kuikka JT, Ahonen AK, Rautio PJ. Quality of dynamic radionuclide renal imaging: multicentre evaluation using a functional renal phantom. Nucl Med Commun. 2001;22:987-995.
27. SabbirAhmed AS. Demir M, Kabasakal L, Uslu I. A dynamic renal phantom for nuclear medicine studies. Med Phys. 2005;32:530-538.
28. Lee KJ, Barber DC. Automatic motion correction in dynamic radionuclide renography using image registration. Nucl Med Commun. 1998;19:1159-1167.
29. Taylor A, Garcia EV, Halkar R, Folks R, Krishnan M. Use of an expert system, RENEX, to determine the need for furosemide in patients with suspected renal obstruction [abstract]. J Nucl Med. 2005;46(suppl):23P.